Wang N, Gu Y, Li L, et al. J Inflamm Res. 2022;15:3477–3499.
The authors have advised due to an error that occurred inadvertently at the time of figure assembly, the scratch test result of si-SDC1 MBA-MD-231 cells were wrongly placed in the position of the scratch test results of si-SORBS1 MCF-7 cells and therefore, figure part 8F is incorrect.
The correct Figure 8 is shown below.
Figure 8.
Effects of SORBS1 knockdown or overexpression on BC cells’ invasion and migration. (A) Quantitative PCR analysis of SORBS1 expression levels in si-SORBS1 control, si-SORBS1, oe-SORBS1 control and oe-SORBS1 breast cancer cell lines (MCF-7 and MDA-MB-231). (B) Western blot of SORBS1 expression levels in si-SORBS1 control, si-SORBS1, oe-SORBS1 control and oe-SORBS1 breast cancer cell lines (MCF-7 and MDA-MB-231). (C) Effects of SORBS1 knockdown or overexpressed on invasion of MDA-MB-231 breast cancer cells. (D) Effects of SORBS1 knockdown or overexpressed on invasion of MCF-7 breast cancer cells. (E) Effects of SORBS1 knockdown or overexpressed on migration of MDA-MB-231 breast cancer cells showed by scratch assays. (F) Effects of SORBS1 knockdown or overexpressed on migration of MCF-7 breast cancer cells showed by scratch assays. **P < 0.01; ***P < 0.001.
The authors apologize for this error and advise it does not affect the results and conclusions of the paper.